Development of Monoclonal Antibody-Based EIA for Tetranor-PGDM which Reflects PGD(2) Production in the Body

Tetranor-PGDM is a metabolite of PGD(2). Urinary tetranor-PGDM levels were reported to be increased in some diseases, including food allergy, Duchenne muscular dystrophy, and aspirin-intolerant asthma. In this study, we developed a monoclonal antibody (MAb) and a competitive enzyme immunoassay (EIA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagata, Nanae, Masuko, Sakura, Inoue, Rikako, Nakamura, Tatsuro, Aritake, Kosuke, Murata, Takahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096570/
https://www.ncbi.nlm.nih.gov/pubmed/33997056
http://dx.doi.org/10.1155/2021/5591115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096570/
https://www.ncbi.nlm.nih.gov/pubmed/33997056
http://dx.doi.org/10.1155/2021/5591115

Ejemplares similares